25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biocardia Inc
Buy, Hold or Sell?

Let's analyze Biocardia together

I guess you are interested in Biocardia Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biocardia Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biocardia Inc

I send you an email if I find something interesting about Biocardia Inc.

1. Quick Overview

1.1. Quick analysis of Biocardia (30 sec.)










1.2. What can you expect buying and holding a share of Biocardia? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.60
Expected worth in 1 year
$1.35
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.74
Return On Investment
35.1%

For what price can you sell your share?

Current Price per Share
$2.12
Expected price per share
$1.625 - $2.57
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biocardia (5 min.)




Live pricePrice per Share (EOD)
$2.12
Intrinsic Value Per Share
$-28.46 - $-18.94
Total Value Per Share
$-27.86 - $-18.34

2.2. Growth of Biocardia (5 min.)




Is Biocardia growing?

Current yearPrevious yearGrowGrow %
How rich?$2.7m$1.9m-$2.7m-351.7%

How much money is Biocardia making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$3.1m$1.2m62.2%
Net Profit Margin-18,731.7%-4,251.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Biocardia (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#723 / 933

Most Revenue
#720 / 933

Most Profit
#279 / 933

Most Efficient
#881 / 933
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biocardia?

Welcome investor! Biocardia's management wants to use your money to grow the business. In return you get a share of Biocardia.

First you should know what it really means to hold a share of Biocardia. And how you can make/lose money.

Speculation

The Price per Share of Biocardia is $2.121. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biocardia.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biocardia, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.60. Based on the TTM, the Book Value Change Per Share is $0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biocardia.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.38-17.9%-0.42-19.9%-0.27-12.6%-0.31-14.5%-0.34-16.0%
Usd Book Value Change Per Share1.0348.5%0.198.8%-0.09-4.4%-0.01-0.6%-0.06-2.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.0348.5%0.198.8%-0.09-4.4%-0.01-0.6%-0.06-2.8%
Usd Price Per Share3.12-1.79-1.78-2.42-1.89-
Price to Earnings Ratio-2.06--1.17--2.53--2.61--1.26-
Price-to-Total Gains Ratio3.03-10.10--37.14--17.66--8.95-
Price to Book Ratio5.20--1.12-14.71-5.98-2.87-
Price-to-Total Gains Ratio3.03-10.10--37.14--17.66--8.95-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.121
Number of shares471
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.19-0.01
Usd Total Gains Per Share0.19-0.01
Gains per Quarter (471 shares)87.66-6.14
Gains per Year (471 shares)350.66-24.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103513410-25-35
207016920-49-60
30105210430-74-85
40140313940-98-110
50175317450-123-135
60210420960-147-160
70245524470-172-185
80280527980-196-210
90315631490-221-235
100350735000-246-260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%8.032.00.020.0%18.092.03.015.9%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.014.01.025.0%13.024.03.032.5%34.073.06.030.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.0111.01.8%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.014.01.025.0%13.024.03.032.5%34.073.06.030.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biocardia Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0280.186+452%-0.093+109%-0.013+101%-0.059+106%
Book Value Per Share--0.601-0.168+128%0.074+708%0.361+66%1.615-63%
Current Ratio--1.7800.720+147%1.359+31%2.312-23%838.732-100%
Debt To Asset Ratio--0.5611.406-60%0.789-29%0.687-18%0.385+46%
Debt To Equity Ratio--1.2760.319+300%1.665-23%0.938+36%0.508+151%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--15718953.6005830736.484+170%33278293.006-53%35819325.212-56%27545007.164-43%
Eps---0.379-0.421+11%-0.267-30%-0.307-19%-0.338-11%
Ev To Ebitda Ratio---2.258-0.880-61%-2.517+11%-2.867+27%9.812-123%
Ev To Sales Ratio--infinfnan%140.446+inf%infnan%infnan%
Free Cash Flow Per Share---0.570-0.399-30%-0.243-57%-0.269-53%-0.305-46%
Free Cash Flow To Equity Per Share--0.7650.169+354%-0.163+121%0.000+203775%0.059+1191%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0050%
Intrinsic Value_10Y_max---18.940--------
Intrinsic Value_10Y_min---28.460--------
Intrinsic Value_1Y_max---1.183--------
Intrinsic Value_1Y_min---1.507--------
Intrinsic Value_3Y_max---4.099--------
Intrinsic Value_3Y_min---5.720--------
Intrinsic Value_5Y_max---7.672--------
Intrinsic Value_5Y_min---11.206--------
Market Cap9723257.880-47%14302953.6008207236.484+74%33510793.006-57%32073925.212-55%19377057.164-26%
Net Profit Margin----187.3170%-42.5150%-74.8500%-45.0450%
Operating Margin----189.4690%-42.7740%-75.8300%-45.4840%
Operating Ratio---197.418-100%72.841-100%92.258-100%54.490-100%
Pb Ratio3.532-47%5.195-1.117+121%14.710-65%5.983-13%2.868+81%
Pe Ratio-1.399+32%-2.059-1.175-43%-2.534+23%-2.607+27%-1.263-39%
Price Per Share2.121-47%3.1201.790+74%1.785+75%2.418+29%1.893+65%
Price To Free Cash Flow Ratio-0.930+32%-1.368-1.168-15%-2.885+111%-3.039+122%-1.731+27%
Price To Total Gains Ratio2.063-47%3.03410.097-70%-37.139+1324%-17.656+682%-8.952+395%
Quick Ratio--1.7390.665+161%1.292+35%2.230-22%837.021-100%
Return On Assets---0.277-0.597+115%-0.506+82%-0.381+37%-0.326+18%
Return On Equity---0.631-0.158-75%-1.138+80%-0.610-3%-0.459-27%
Total Gains Per Share--1.0280.186+452%-0.093+109%-0.013+101%-0.059+106%
Usd Book Value--2753000.000-771500.000+128%1941750.000+42%5811150.000-53%9518200.000-71%
Usd Book Value Change Per Share--1.0280.186+452%-0.093+109%-0.013+101%-0.059+106%
Usd Book Value Per Share--0.601-0.168+128%0.074+708%0.361+66%1.615-63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--15718953.6005830736.484+170%33278293.006-53%35819325.212-56%27545007.164-43%
Usd Eps---0.379-0.421+11%-0.267-30%-0.307-19%-0.338-11%
Usd Free Cash Flow---2613000.000-1827250.000-30%-2783500.000+7%-2623200.000+0%-2115450.000-19%
Usd Free Cash Flow Per Share---0.570-0.399-30%-0.243-57%-0.269-53%-0.305-46%
Usd Free Cash Flow To Equity Per Share--0.7650.169+354%-0.163+121%0.000+203775%0.059+1191%
Usd Market Cap9723257.880-47%14302953.6008207236.484+74%33510793.006-57%32073925.212-55%19377057.164-26%
Usd Price Per Share2.121-47%3.1201.790+74%1.785+75%2.418+29%1.893+65%
Usd Profit---1737000.000-1930500.000+11%-3132000.000+80%-2958300.000+70%-2664300.000+53%
Usd Revenue---17750.000-100%142500.000-100%171950.000-100%153675.000-100%
Usd Total Gains Per Share--1.0280.186+452%-0.093+109%-0.013+101%-0.059+106%
 EOD+2 -6MRQTTM+24 -10YOY+23 -125Y+17 -1710Y+12 -23

3.3 Fundamental Score

Let's check the fundamental score of Biocardia Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.399
Price to Book Ratio (EOD)Between0-13.532
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.739
Current Ratio (MRQ)Greater than11.780
Debt to Asset Ratio (MRQ)Less than10.561
Debt to Equity Ratio (MRQ)Less than11.276
Return on Equity (MRQ)Greater than0.15-0.631
Return on Assets (MRQ)Greater than0.05-0.277
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Biocardia Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.690
Ma 20Greater thanMa 502.171
Ma 50Greater thanMa 1002.198
Ma 100Greater thanMa 2002.435
OpenGreater thanClose2.260
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biocardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.

Fundamental data was last updated by Penke on 2025-01-16 13:55:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biocardia earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biocardia Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18,731.7%+18,731.7%
TTM-18,731.7%YOY-4,251.5%-14,480.2%
TTM-18,731.7%5Y-7,485.0%-11,246.7%
5Y-7,485.0%10Y-4,504.5%-2,980.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--104.6%+104.6%
TTM-18,731.7%-216.4%-18,515.3%
YOY-4,251.5%-208.6%-4,042.9%
5Y-7,485.0%-353.9%-7,131.1%
10Y-4,504.5%-488.0%-4,016.5%
4.3.1.2. Return on Assets

Shows how efficient Biocardia is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • -27.7% Return on Assets means that Biocardia generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biocardia Inc:

  • The MRQ is -27.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -59.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.7%TTM-59.7%+31.9%
TTM-59.7%YOY-50.6%-9.1%
TTM-59.7%5Y-38.1%-21.6%
5Y-38.1%10Y-32.6%-5.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.7%-12.7%-15.0%
TTM-59.7%-13.0%-46.7%
YOY-50.6%-12.3%-38.3%
5Y-38.1%-13.7%-24.4%
10Y-32.6%-15.7%-16.9%
4.3.1.3. Return on Equity

Shows how efficient Biocardia is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • -63.1% Return on Equity means Biocardia generated $-0.63 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biocardia Inc:

  • The MRQ is -63.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-63.1%TTM-15.8%-47.3%
TTM-15.8%YOY-113.8%+98.1%
TTM-15.8%5Y-61.0%+45.3%
5Y-61.0%10Y-45.9%-15.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.1%-16.8%-46.3%
TTM-15.8%-17.8%+2.0%
YOY-113.8%-16.4%-97.4%
5Y-61.0%-20.6%-40.4%
10Y-45.9%-21.2%-24.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biocardia Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biocardia is operating .

  • Measures how much profit Biocardia makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biocardia Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18,946.9%+18,946.9%
TTM-18,946.9%YOY-4,277.4%-14,669.5%
TTM-18,946.9%5Y-7,583.0%-11,363.9%
5Y-7,583.0%10Y-4,548.4%-3,034.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--193.6%+193.6%
TTM-18,946.9%-321.1%-18,625.8%
YOY-4,277.4%-227.9%-4,049.5%
5Y-7,583.0%-373.0%-7,210.0%
10Y-4,548.4%-506.1%-4,042.3%
4.3.2.2. Operating Ratio

Measures how efficient Biocardia is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biocardia Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM197.418-197.418
TTM197.418YOY72.841+124.577
TTM197.4185Y92.258+105.160
5Y92.25810Y54.490+37.768
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.171-2.171
TTM197.4183.250+194.168
YOY72.8413.231+69.610
5Y92.2584.838+87.420
10Y54.4906.440+48.050
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biocardia Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biocardia is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.78 means the company has $1.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biocardia Inc:

  • The MRQ is 1.780. The company is able to pay all its short-term debts. +1
  • The TTM is 0.720. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ1.780TTM0.720+1.060
TTM0.720YOY1.359-0.639
TTM0.7205Y2.312-1.592
5Y2.31210Y838.732-836.420
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7803.610-1.830
TTM0.7203.850-3.130
YOY1.3594.605-3.246
5Y2.3125.895-3.583
10Y838.7326.178+832.554
4.4.3.2. Quick Ratio

Measures if Biocardia is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Quick Ratio of 1.74 means the company can pay off $1.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biocardia Inc:

  • The MRQ is 1.739. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 0.665. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.739TTM0.665+1.074
TTM0.665YOY1.292-0.626
TTM0.6655Y2.230-1.565
5Y2.23010Y837.021-834.791
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7393.034-1.295
TTM0.6653.355-2.690
YOY1.2924.297-3.005
5Y2.2305.890-3.660
10Y837.0216.434+830.587
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biocardia Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biocardia assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biocardia to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56 means that Biocardia assets are financed with 56.1% credit (debt) and the remaining percentage (100% - 56.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biocardia Inc:

  • The MRQ is 0.561. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 1.406. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ0.561TTM1.406-0.846
TTM1.406YOY0.789+0.618
TTM1.4065Y0.687+0.720
5Y0.68710Y0.385+0.302
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5610.341+0.220
TTM1.4060.343+1.063
YOY0.7890.310+0.479
5Y0.6870.366+0.321
10Y0.3850.3850.000
4.5.4.2. Debt to Equity Ratio

Measures if Biocardia is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Debt to Equity ratio of 127.6% means that company has $1.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biocardia Inc:

  • The MRQ is 1.276. The company is able to pay all its debts with equity. +1
  • The TTM is 0.319. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.276TTM0.319+0.957
TTM0.319YOY1.665-1.346
TTM0.3195Y0.938-0.619
5Y0.93810Y0.508+0.430
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2760.393+0.883
TTM0.3190.429-0.110
YOY1.6650.382+1.283
5Y0.9380.439+0.499
10Y0.5080.489+0.019
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biocardia generates.

  • Above 15 is considered overpriced but always compare Biocardia to the Biotechnology industry mean.
  • A PE ratio of -2.06 means the investor is paying $-2.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biocardia Inc:

  • The EOD is -1.399. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.059. Based on the earnings, the company is expensive. -2
  • The TTM is -1.175. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.399MRQ-2.059+0.659
MRQ-2.059TTM-1.175-0.884
TTM-1.175YOY-2.534+1.359
TTM-1.1755Y-2.607+1.432
5Y-2.60710Y-1.263-1.344
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.399-2.247+0.848
MRQ-2.059-2.693+0.634
TTM-1.175-3.214+2.039
YOY-2.534-3.335+0.801
5Y-2.607-6.368+3.761
10Y-1.263-6.692+5.429
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biocardia Inc:

  • The EOD is -0.930. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.368. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.168. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.930MRQ-1.368+0.438
MRQ-1.368TTM-1.168-0.200
TTM-1.168YOY-2.885+1.717
TTM-1.1685Y-3.039+1.871
5Y-3.03910Y-1.731-1.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.930-2.993+2.063
MRQ-1.368-3.671+2.303
TTM-1.168-4.037+2.869
YOY-2.885-4.482+1.597
5Y-3.039-8.190+5.151
10Y-1.731-9.383+7.652
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biocardia is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.20 means the investor is paying $5.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biocardia Inc:

  • The EOD is 3.532. Based on the equity, the company is fair priced.
  • The MRQ is 5.195. Based on the equity, the company is overpriced. -1
  • The TTM is -1.117. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.532MRQ5.195-1.664
MRQ5.195TTM-1.117+6.312
TTM-1.117YOY14.710-15.827
TTM-1.1175Y5.983-7.100
5Y5.98310Y2.868+3.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5321.933+1.599
MRQ5.1952.265+2.930
TTM-1.1172.447-3.564
YOY14.7102.454+12.256
5Y5.9833.664+2.319
10Y2.8684.239-1.371
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biocardia Inc.

4.8.1. Institutions holding Biocardia Inc

Institutions are holding 2.215% of the shares of Biocardia Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Susquehanna International Group, LLP1.540705962603958.4398
2024-09-30Geode Capital Management, LLC0.3214014736171513.171
2024-09-30Vanguard Group Inc0.28101288400
2024-09-30Tower Research Capital LLC0.0280.00011282-1754-57.7734
2024-09-30Pingora Partners LLC0.02260.0023103600
2024-09-30Bank of America Corp0.0097044620.4505
2024-09-30Global Retirement Partners, LLC.0.009041100
2024-09-30Advisor Group Holdings, Inc.0.0013061610
2024-09-30Morgan Stanley - Brokerage Accounts0.0007030-30-50
2024-06-30Royal Bank of Canada0.0006026260
2024-06-30State Street Corp000-1400-100
2024-06-30CM Management, LLC000-46662-100
2024-06-30Wells Fargo & Co000-7-100
2024-06-30Octavia Wealth Advisors, LLC000-949-100
2024-06-30Commonwealth Equity Services Inc000-2000-100
2024-06-30Northern Trust Corp000-1282-100
2024-06-30SIMPLEX TRADING, LLC000-480-100
2024-06-30Wedbush Morgan Securities Inc000-1000-100
2024-06-30Brown Advisory Holdings Inc000-2205-100
2024-06-30Family Management Corporation000-5166-100
Total 2.21430.0024101508-35092-34.6%

4.9.2. Funds holding Biocardia Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-30Vanguard Institutional Extnd Mkt Idx Tr0.275201261600
2024-11-30Fidelity Extended Market Index0.172707915-52-0.6527
2024-11-30Fidelity Total Market Index0.07060323700
2024-11-30Fidelity Nasdaq Composite Index0.04720216200
2024-11-30Fidelity Series Total Market Index0.042301938-1026-34.6154
2024-09-30Northern Trust Extended Eq Market Idx0.0146066800
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0146066800
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0124056700
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.01045710.2193
2024-11-30Vanguard U.S. Eq Idx £ Acc0.0058026800
2024-11-30Spartan Total Market Index Pool E0.0058026600
2024-11-30Spartan Extended Market Index Pool E0.004402025234.6667
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0022010300
2024-12-31State St US Extended Mkt Indx NL Cl C0.0022010000
2024-06-30Blackstone Alternative Multi-Strategy I0.001047470
2024-09-30Northern Trust Wilshire 50000.00104600
2024-09-30Aptus Impact Series Growth0.00090.00014100
2024-06-30SSgA U.S. Total Market Index Strategy0.00090411241.3793
Total 0.68380.000131342-966-3.1%

5.3. Insider Transactions

Insiders are holding 14.071% of the shares of Biocardia Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-23Peter AltmanBUY10002.06
2024-12-20Edward M GillisSELL32572
2024-12-05Peter AltmanBUY2502.22
2024-11-15Peter AltmanBUY13501.87
2024-07-01Peter AltmanBUY3003.05
2024-06-28Peter AltmanBUY2002.99
2024-06-21Peter AltmanBUY5003.29
2024-06-14Peter AltmanBUY5003.52
2024-06-10Peter AltmanBUY10003.36
2024-04-19Peter AltmanBUY1835.55
2024-03-28Peter AltmanBUY335.85
2024-02-13Peter AltmanBUY72076.9
2024-01-19Phillip Md Et Al FrostSELL86536.45
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Total Stockholder Equity -660-943-1,603-672-2,275314-1,9614,7142,753
Net Working Capital  -1,214-933-2,147-665-2,812314-2,4984,7142,216
Net Invested Capital  -660-943-1,603-672-2,275314-1,9614,7142,753



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,267
Total Liabilities3,514
Total Stockholder Equity2,753
 As reported
Total Liabilities 3,514
Total Stockholder Equity+ 2,753
Total Assets = 6,267

Assets

Total Assets6,267
Total Current Assets5,056
Long-term Assets1,211
Total Current Assets
Cash And Cash Equivalents 4,930
Net Receivables 10
Other Current Assets 116
Total Current Assets  (as reported)5,056
Total Current Assets  (calculated)5,056
+/-0
Long-term Assets
Property Plant Equipment 1,040
Long-term Assets Other 171
Long-term Assets  (as reported)1,211
Long-term Assets  (calculated)1,211
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,840
Long-term Liabilities674
Total Stockholder Equity2,753
Total Current Liabilities
Short-term Debt 371
Accounts payable 569
Other Current Liabilities 1,361
Total Current Liabilities  (as reported)2,840
Total Current Liabilities  (calculated)2,301
+/- 539
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt674
Long-term Liabilities  (as reported)674
Long-term Liabilities  (calculated)674
+/-0
Total Stockholder Equity
Common Stock5
Retained Earnings -157,825
Other Stockholders Equity 160,573
Total Stockholder Equity (as reported)2,753
Total Stockholder Equity (calculated)2,753
+/-0
Other
Capital Stock5
Cash and Short Term Investments 4,930
Common Stock Shares Outstanding 2,827
Current Deferred Revenue539
Liabilities and Stockholders Equity 6,267
Net Debt -3,885
Net Invested Capital 2,753
Net Working Capital 2,216
Property Plant and Equipment Gross 1,786
Short Long Term Debt Total 1,045



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-30
> Total Assets 
900
5,200
4,700
4,700
4,700
4,500
4,200
4,100
3,500
3,400
3,200
3,200
2,600
2,400
4,055
7,429
7,588
6,682
6,271
4,187
3,643
3,380
3,119
2,961
2,616
2,580
2,394
2,642
2,484
2,093
1,931
1,706
1,537
1,457
882
897
897
175
152
141
115
102
95
87
1,547
1,444
2,697
2,661
14,230
11,474
10,445
12,420
11,239
15,588
15,089
13,720
5,643
5,435
5,484
14,646
14,001
13,734
13,636
12,940
13,391
13,301
13,275
13,277
13,308
13,328
13,375
13,441
13,488
13,545
13,620
13,697
13,776
13,876
13,948
14,023
19,483
22,082
19,780
17,756
15,860
13,538
10,411
7,661
5,556
6,417
6,417
2,716
10,681
7,678
7,678
13,128
9,502
23,424
23,308
20,218
17,330
15,718
12,840
11,266
9,179
9,793
7,128
6,389
3,747
2,987
2,679
2,890
6,267
6,2672,8902,6792,9873,7476,3897,1289,7939,17911,26612,84015,71817,33020,21823,30823,4249,50213,1287,6787,67810,6812,7166,4176,4175,5567,66110,41113,53815,86017,75619,78022,08219,48314,02313,94813,87613,77613,69713,62013,54513,48813,44113,37513,32813,30813,27713,27513,30113,39112,94013,63613,73414,00114,6465,4845,4355,64313,72015,08915,58811,23912,42010,44511,47414,2302,6612,6971,4441,54787951021151411521758978978821,4571,5371,7061,9312,0932,4842,6422,3942,5802,6162,9613,1193,3803,6434,1876,2716,6827,5887,4294,0552,4002,6003,2003,2003,4003,5004,1004,2004,5004,7004,7004,7005,200900
   > Total Current Assets 
500
4,900
4,400
4,500
4,500
4,200
3,900
3,800
3,200
3,100
2,800
2,900
2,200
2,100
3,733
7,107
6,773
5,949
5,581
3,787
3,314
3,075
2,836
2,702
2,378
2,356
2,188
2,455
2,313
1,931
1,787
1,656
1,488
1,407
882
897
897
175
152
141
115
102
95
87
1,547
1,444
2,697
2,661
5,804
4,330
3,126
5,180
3,922
8,601
8,089
6,706
3,837
639
740
14,646
14,001
13,734
13,636
12,940
13,391
13,301
13,275
13,277
13,308
13,328
13,375
13,441
13,488
13,545
13,620
13,697
13,776
13,876
13,948
14,023
19,483
21,917
19,549
17,522
15,643
13,315
10,205
7,443
5,348
6,218
6,218
1,152
9,237
6,378
6,378
12,096
8,590
22,658
22,659
19,741
17,006
13,481
10,661
9,152
7,154
7,864
5,289
4,650
2,116
1,461
1,259
1,573
5,056
5,0561,5731,2591,4612,1164,6505,2897,8647,1549,15210,66113,48117,00619,74122,65922,6588,59012,0966,3786,3789,2371,1526,2186,2185,3487,44310,20513,31515,64317,52219,54921,91719,48314,02313,94813,87613,77613,69713,62013,54513,48813,44113,37513,32813,30813,27713,27513,30113,39112,94013,63613,73414,00114,6467406393,8376,7068,0898,6013,9225,1803,1264,3305,8042,6612,6971,4441,54787951021151411521758978978821,4071,4881,6561,7871,9312,3132,4552,1882,3562,3782,7022,8363,0753,3143,7875,5815,9496,7737,1073,7332,1002,2002,9002,8003,1003,2003,8003,9004,2004,5004,5004,4004,900500
       Cash And Cash Equivalents 
0
3,100
1,000
200
200
400
200
1,400
1,200
2,100
1,800
1,800
1,100
900
2,506
5,976
5,568
4,891
4,586
2,558
2,337
2,052
1,869
1,917
1,731
1,679
1,217
1,799
1,654
1,221
1,162
731
967
1,032
840
871
871
153
133
129
108
97
89
82
1,544
1,419
2,680
2,652
4,582
3,095
1,680
3,250
1,607
4,973
3,688
1,665
196
127
241
12,692
12,608
12,678
12,652
12,884
12,823
13,268
13,254
13,269
13,263
13,295
13,322
13,401
13,456
13,509
13,598
13,688
13,726
13,840
13,925
13,872
19,437
21,352
19,032
15,109
13,326
12,689
9,653
6,834
4,820
5,358
5,358
517
8,910
5,585
5,585
11,086
7,392
21,407
21,502
18,543
15,888
12,872
9,930
8,614
6,667
7,363
4,857
4,305
1,835
1,103
949
1,421
4,930
4,9301,4219491,1031,8354,3054,8577,3636,6678,6149,93012,87215,88818,54321,50221,4077,39211,0865,5855,5858,9105175,3585,3584,8206,8349,65312,68913,32615,10919,03221,35219,43713,87213,92513,84013,72613,68813,59813,50913,45613,40113,32213,29513,26313,26913,25413,26812,82312,88412,65212,67812,60812,6922411271961,6653,6884,9731,6073,2501,6803,0954,5822,6522,6801,4191,5448289971081291331538718718401,0329677311,1621,2211,6541,7991,2171,6791,7311,9171,8692,0522,3372,5584,5864,8915,5685,9762,5069001,1001,8001,8002,1001,2001,4002004002002001,0003,1000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
400
600
1,000
669
601
340
286
369
403
251
327
359
320
298
281
608
181
284
348
307
537
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,796
1,799
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001,7991,796000000000000000000000000000000000000000000000000002005373073482841816082812983203593272514033692863406016691,00060040000000000000
       Net Receivables 
400
400
400
400
400
500
1,600
400
400
500
400
600
400
500
476
453
439
389
329
356
313
344
319
381
285
291
279
436
340
278
258
328
275
292
0
0
275
292
0
0
0
0
0
0
0
0
0
0
289
186
265
240
251
307
678
567
486
413
424
460
162
67
24
24
556
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
0
74
121
142
90
95
127
191
170
274
274
204
103
147
147
733
1,066
850
813
791
760
147
326
211
300
201
153
115
104
63
58
10
10
101058631041151532013002113261477607918138501,0667331471471032042742741701911279590142121740142000000000000005562424671624604244134865676783072512402651862890000000000292275002922753282582783404362792912853813193443133563293894394534765004006004005004004001,600500400400400400400
       Other Current Assets 
100
1,400
3,000
3,900
3,900
3,300
2,100
2,000
1,600
500
600
100
100
200
82
77
426
383
298
470
413
353
289
84
64
105
83
40
35
84
60
60
45
83
42
27
27
22
1
12
7
5
6
5
4
25
17
10
78
107
101
114
71
65
53
84
110
99
75
1,494
1,231
989
960
32
12
33
21
8
45
33
53
40
32
36
22
9
50
36
23
9
46
356
252
282
188
340
277
282
224
445
445
426
179
1,707
642
277
132
401
344
407
358
462
405
327
187
300
279
230
177
295
252
142
116
1161422522951772302793001873274054623584073444011322776421,7071794264454452242822773401882822523564692336509223632405333458213312329609891,2311,4947599110845365711141011077810172545657121222727428345606084354083105648428935341347029838342677822001001006005001,6002,0002,1003,3003,9003,9003,0001,400100
   > Long-term Assets 
400
300
300
200
200
300
300
300
300
300
400
300
400
300
322
322
815
733
690
401
330
305
283
260
237
224
206
187
171
162
144
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,426
7,144
7,319
7,240
7,317
6,987
7,000
7,014
1,806
4,796
4,744
0
0
0
0
0
0
33
0
0
0
33
0
0
0
36
0
0
0
36
0
0
0
165
231
234
217
223
206
218
208
145
199
1,564
1,444
1,300
1,300
1,032
912
766
649
477
324
2,237
2,179
2,114
2,025
1,929
1,839
1,739
1,631
1,526
1,420
1,317
1,211
1,2111,3171,4201,5261,6311,7391,8391,9292,0252,1142,1792,2373244776497669121,0321,3001,3001,4441,564199145208218206223217234231165000360003600033000330000004,7444,7961,8067,0147,0006,9877,3177,2407,3197,1448,42600000000000000505050144162171187206224237260283305330401690733815322322300400300400300300300300300200200300300400
       Property Plant Equipment 
200
200
200
200
200
300
300
200
300
300
300
300
300
300
290
291
315
356
334
309
287
262
240
217
194
181
163
144
128
119
102
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
366
716
1,057
1,152
1,226
1,228
1,417
1,607
1,774
1,775
1,775
0
0
0
0
0
0
0
0
0
0
66
0
0
0
72
0
0
0
150
0
0
0
111
177
180
163
169
152
164
154
145
145
1,510
1,390
1,246
1,246
978
858
712
596
477
324
2,065
2,007
1,943
1,853
1,758
1,667
1,568
1,460
1,355
1,249
1,146
1,040
1,0401,1461,2491,3551,4601,5681,6671,7581,8531,9432,0072,0653244775967128589781,2461,2461,3901,510145145154164152169163180177111000150000720006600000000001,7751,7751,7741,6071,4171,2281,2261,1521,05771636600000000000000000102119128144163181194217240262287309334356315291290300300300300300300200300300200200200200200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,690
1,233
1,233
1,233
1,233
1,233
1,233
1,233
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000001,2331,2331,2331,2331,2331,2331,2332,690000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,165
5,003
4,840
4,678
4,515
4,353
4,190
4,027
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000004,0274,1904,3534,5154,6784,8405,0035,165000000000000000000000000000000000000000000000000
       Long-term Assets Other 
200
100
100
0
100
0
0
100
0
0
100
0
100
0
32
31
500
377
356
91
43
43
43
43
43
43
43
43
43
43
42
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205
192
189
177
343
173
160
147
32
3,021
4,744
0
0
0
0
0
0
33
0
0
0
33
0
0
0
36
0
0
0
36
0
0
0
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
53
293
0
172
172
171
172
171
172
171
171
171
171
171
171
1711711711711711711721711721711721720293535454545454545454545454545454545454000360003600033000330000004,7443,021321471601733431771891922050000000000000050505042434343434343434343439135637750031320100010000100001000100100200
> Total Liabilities 
1,000
700
500
600
600
500
400
700
900
700
800
1,000
900
700
937
1,163
1,151
1,012
1,054
783
888
782
823
868
788
814
843
963
960
753
793
742
806
784
708
721
721
33
29
25
15
16
21
26
92
9
-2,697
15
933
777
941
1,201
1,028
851
1,789
1,884
1,905
2,156
2,515
270
744
756
711
142
141
12
10
3
3
18
1
1
5
1
-13,620
4
83
10
-13,948
-14,023
330
1,500
1,430
1,675
2,075
2,413
2,204
1,903
2,612
2,625
2,625
4,952
5,487
5,308
5,308
5,837
5,389
4,248
4,746
4,545
3,918
5,343
5,471
4,532
5,082
4,901
5,228
4,754
4,407
4,590
4,954
4,851
3,514
3,5144,8514,9544,5904,4074,7545,2284,9015,0824,5325,4715,3433,9184,5454,7464,2485,3895,8375,3085,3085,4874,9522,6252,6252,6121,9032,2042,4132,0751,6751,4301,500330-14,023-13,94810834-13,6201511183310121411427117567442702,5152,1561,9051,8841,7898511,0281,20194177793315-2,697992262116152529337217217087848067427937539609638438147888688237828887831,0541,0121,1511,1639377009001,0008007009007004005006006005007001,000
   > Total Current Liabilities 
1,000
700
500
600
600
500
500
800
900
700
700
1,000
900
700
937
1,163
1,151
1,012
1,054
783
888
782
823
868
788
814
843
963
960
753
793
742
806
784
708
721
721
33
29
25
15
16
21
26
92
9
0
15
933
777
941
1,201
1,028
851
1,789
1,884
1,905
2,156
2,515
270
744
756
711
142
141
12
10
3
3
18
1
1
5
1
1
4
0
10
10
0
330
1,444
1,368
1,607
2,000
2,332
2,121
1,819
2,532
2,548
2,548
4,066
4,044
4,003
4,003
4,551
4,320
4,248
4,746
4,545
3,918
3,712
3,913
3,054
3,684
3,585
4,000
3,616
3,330
3,608
4,071
4,071
2,840
2,8404,0714,0713,6083,3303,6164,0003,5853,6843,0543,9133,7123,9184,5454,7464,2484,3204,5514,0034,0034,0444,0662,5482,5482,5321,8192,1212,3322,0001,6071,3681,444330010100411511183310121411427117567442702,5152,1561,9051,8841,7898511,0281,201941777933150992262116152529337217217087848067427937539609638438147888688237828887831,0541,0121,1511,1639377009001,0007007009008005005006006005007001,000
       Short-term Debt 
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
280
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
1,224
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
478
658
263
7
124
75
43
15
0
126
488
508
0
528
796
876
614
468
316
161
237
281
292
304
315
327
340
321
666
1,040
716
371
3717161,04066632134032731530429228123716131646861487679652805084881260154375124726365847800000000000000000000001,2245000000000000000000000000000000280000000000000000000000000000400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
469
0
0
0
0
226
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002842260000469000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
100
100
200
200
200
100
100
300
400
300
200
300
300
300
247
406
251
223
194
179
222
211
131
258
119
197
116
278
196
179
195
242
197
189
4
12
12
0
0
8
3
1
1
4
74
9
0
15
933
0
0
0
0
0
0
0
0
1,299
0
830
744
127
0
0
0
0
10
3
0
18
1
1
5
1
0
4
0
10
0
0
330
525
291
590
447
902
738
505
1,102
2,548
1,020
1,626
1,112
914
914
1,525
1,208
746
850
970
846
507
764
999
887
683
861
686
507
890
1,030
1,447
569
5691,4471,0308905076868616838879997645078469708507461,2081,5259149141,1121,6261,0202,5481,10250573890244759029152533000100401511180310000012774483001,29900000000933150974411380012124189197242195179196278116197119258131211222179194223251406247300300300200300400300100100200200200100100
       Other Current Liabilities 
500
600
300
400
400
400
400
500
500
400
500
700
600
400
690
756
901
789
591
319
332
282
364
308
366
346
444
417
220
376
384
327
375
383
705
709
709
33
29
17
13
16
20
22
18
0
0
0
0
777
941
1,201
1,028
851
1,789
1,884
1,905
357
1,291
270
744
629
711
142
141
12
0
0
3
18
1
1
5
1
0
4
0
10
0
0
330
304
285
269
669
663
654
635
666
77
645
1,213
1,535
732
1,829
1,504
1,526
1,500
1,548
1,147
1,329
1,435
1,237
1,111
1,469
1,622
1,864
1,666
1,921
2,052
2,135
1,908
1,361
1,3611,9082,1352,0521,9211,6661,8641,6221,4691,1111,2371,4351,3291,1471,5481,5001,5261,5041,8297321,5351,213645776666356546636692692853043300010040151118300121411427116297442701,2913571,9051,8841,7898511,0281,20194177700001822201613172933709709705383375327384376220417444346366308364282332319591789901756690400600700500400500500400400400400300600500
   > Long-term Liabilities 
500
100
200
0
200
100
-100
-100
400
300
100
300
300
300
247
406
251
223
464
463
556
500
460
561
422
469
399
547
460
378
409
415
431
401
4
0
12
0
0
8
3
1
1
4
74
9
0
15
933
0
0
0
0
0
0
0
0
1,799
1,224
0
0
127
0
0
0
0
10
3
0
0
0
0
0
0
0
0
83
0
0
0
0
56
62
68
75
81
83
84
80
0
77
886
1,443
1,305
1,305
1,286
1,069
2,748
3,198
3,398
2,589
1,631
1,558
1,478
1,398
1,316
1,228
1,138
1,077
982
883
780
674
6747808839821,0771,1381,2281,3161,3981,4781,5581,6312,5893,3983,1982,7481,0691,2861,3051,3051,4438867708084838175686256000083000000003100000127001,2241,7990000000093315097441138001204401431415409378460547399469422561460500556463464223251406247300300300100300400-100-1001002000200100500
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
0
0
0
31
0
0
0
0
0
0
0
56
62
68
75
81
83
84
80
77
0
0
691
691
689
689
683
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006836896896916910077808483817568625600000003100031000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
62
68
75
81
83
0
0
0
0
0
0
0
689
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006890000000838175686256000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-100
4,500
4,200
4,100
4,100
4,000
3,800
3,400
2,600
2,700
2,400
2,200
1,700
1,700
3,118
6,266
6,436
5,670
5,216
3,405
2,755
2,598
2,296
2,093
1,827
1,766
1,551
1,679
1,524
1,340
1,137
964
732
673
174
177
177
142
123
117
100
86
75
61
1,455
1,435
2,697
2,646
13,297
10,697
9,504
11,219
10,211
14,737
13,300
11,836
3,738
3,279
2,969
14,376
13,257
12,978
12,925
12,798
13,250
13,289
13,265
13,274
13,305
13,310
13,374
13,440
13,483
13,544
13,620
13,693
13,693
13,866
13,948
14,023
19,153
20,582
18,350
16,081
13,785
11,125
8,207
5,758
2,944
3,792
3,792
-2,236
5,194
2,370
2,370
7,291
4,113
19,176
18,562
15,673
13,412
10,375
7,369
6,734
4,097
4,892
1,900
1,635
-660
-1,603
-2,275
-1,961
2,753
2,753-1,961-2,275-1,603-6601,6351,9004,8924,0976,7347,36910,37513,41215,67318,56219,1764,1137,2912,3702,3705,194-2,2363,7923,7922,9445,7588,20711,12513,78516,08118,35020,58219,15314,02313,94813,86613,69313,69313,62013,54413,48313,44013,37413,31013,30513,27413,26513,28913,25012,79812,92512,97813,25714,3762,9693,2793,73811,83613,30014,73710,21111,2199,50410,69713,2972,6462,6971,4351,4556175861001171231421771771746737329641,1371,3401,5241,6791,5511,7661,8272,0932,2962,5982,7553,4055,2165,6706,4366,2663,1181,7001,7002,2002,4002,7002,6003,4003,8004,0004,1004,1004,2004,500-100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
4
4
4
1
1
1
1
1
1
1
1
1
1
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
55
55
11
11
203
203
203
203
706
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
231
458
458
458
38
38
38
38
38
43
43
44
46
7
7
12
12
16
17
17
17
17
17
18
18
20
20
22
22
24
27
2
5
5227242222202018181717171717161212774644434338383838384584584582312302302302302302302302302302302302302302302302302302302302302302302302302302302307062032032032031111555510101010101010101099999911111111114444300000000000000
   Retained Earnings -157,825-156,088-154,442-152,175-150,103-147,529-144,105-140,604-137,576-134,519-132,022-128,697-125,236-122,530-119,043-116,074-113,085-109,237-101,070-101,070-97,568-93,776-86,361-86,361-82,719-79,175-75,988-72,450-68,964-65,963-63,018-60,142-6,854-11,975-12,050-12,132-12,305-12,305-12,378-12,454-12,515-12,558-12,624-12,688-12,693-12,723-12,732-12,707-12,745-13,196-13,067-13,012-12,727-11,599-22,995-22,674-22,215-14,102-12,620-11,165-9,855-8,650-7,311-6,087-3,809-10,359-10,308-10,236-10,190-10,098-10,080-10,065-10,047-10,022-10,012-9,989-9,929-9,929-9,880-9,357-9,297-9,117-8,957-8,745-8,505-8,394-8,451-8,238-8,124-7,915-7,717-7,429-7,159-6,687-6,459-5,908-4,882-4,327-3,583-3,200-3,100-2,700-2,400-2,300-2,200-1,400-1,200-1,000-700-700-300-100-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,795
25,804
0
0
0
0
0
0
0
0
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,776
80,266
80,910
81,586
82,711
83,537
84,157
84,895
85,625
90,110
90,800
91,496
102,716
103,433
104,374
116,516
117,186
135,234
137,588
138,186
0
0
0
0
0
0
145,985
0
0
0
0
0
0
000000145,985000000138,186137,588135,234117,186116,516104,374103,433102,71691,49690,80090,11085,62584,89584,15783,53782,71181,58680,91080,26625,77625,76825,76825,76825,76825,76825,76825,76825,76825,76825,76825,7680000000025,80425,79500000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
4,700
4,600
4,900
4,900
5,100
5,200
4,900
5,100
5,300
5,100
4,800
5,100
5,300
4,982
8,940
9,857
10,080
10,101
10,097
10,035
10,026
10,027
10,027
10,028
10,028
10,028
10,028
10,028
10,020
10,020
10,020
10,020
10,020
10,045
10,096
10,096
10,121
10,125
10,129
10,137
10,141
10,145
10,149
11,615
11,699
12,994
12,994
16,953
16,581
16,612
19,666
19,360
26,411
25,690
25,708
25,723
549,723
25,734
25,745
25,754
25,760
25,762
25,764
25,765
25,766
25,767
25,767
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,776
81,037
81,694
82,393
83,539
84,295
84,936
85,697
86,448
0
90,955
92,390
103,639
0
104,390
117,509
118,194
135,234
137,588
138,186
138,631
139,055
139,374
141,235
141,655
145,476
145,985
149,142
149,421
150,548
152,140
154,125
160,573
160,573154,125152,140150,548149,421149,142145,985145,476141,655141,235139,374139,055138,631138,186137,588135,234118,194117,509104,3900103,63992,39090,955086,44885,69784,93684,29583,53982,39381,69481,03725,77625,76825,76825,76825,76825,76825,76825,76825,76825,76825,76825,76825,76825,76725,76725,76625,76525,76425,76225,76025,75425,74525,734549,72325,72325,70825,69026,41119,36019,66616,61216,58116,95312,99412,99411,69911,61510,14910,14510,14110,13710,12910,12510,12110,09610,09610,04510,02010,02010,02010,02010,02010,02810,02810,02810,02810,02810,02710,02710,02610,03510,09710,10110,0809,8578,9404,9825,3005,1004,8005,1005,3005,1004,9005,2005,1004,9004,9004,6004,7000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.